Literature DB >> 33471982

Treatment by CRISPR-Cas9 Gene Editing - A Proof of Principle.

Harry L Malech1.   

Abstract

Mesh:

Year:  2021        PMID: 33471982     DOI: 10.1056/NEJMe2034624

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

1.  Frequency and mechanisms of LINE-1 retrotransposon insertions at CRISPR/Cas9 sites.

Authors:  Jianli Tao; Qi Wang; Carlos Mendez-Dorantes; Kathleen H Burns; Roberto Chiarle
Journal:  Nat Commun       Date:  2022-06-27       Impact factor: 17.694

2.  The Randomised Controlled Trial at the Intersection of Research Ethics and Innovation.

Authors:  Torbjörn Callréus
Journal:  Pharmaceut Med       Date:  2022-07-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.